Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
Journal of Zhejiang University. Medical sciences ; (6): 174-178, 2015.
Article in Chinese | WPRIM | ID: wpr-255215

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effects of cycle-dependent kinase (CDK) inhibitor SNS-032 on apoptosis in human acute myeloid leukemia (AML) HL-60 cells and its molecular mechanisms.</p><p><b>METHODS</b>Cultured AML HL-60 cells were treated with various concentrations of SNS-032. Cell apoptosis was determined with flow cytometry;cell viability was measured by MTT assay; the profiles of microRNA expression of HL-60 cells were analyzed by microRNA microarray;the protein expressions of JAK2/STAT3 pathway were detected by Western blotting.</p><p><b>RESULTS</b>Apoptosis of AML HL-60 cells was induced by SNS-032; the rate of apoptosis was (5.9±1.7)%, (12.1±3.1)% and (59.4±3.6)% when HL-60 cells were treated with 0,100 and 200 nmol/L SNS-032. MicroRNA microarray analysis revealed that the levels of miR-30a, miR-183, miR-20b, miR-26b, miR-20a, miR-589, miR-107, miR-181a, miR-106a, miR-17 and miR-378c were down-regulated by SNS-032,whereas the levels of miR-320a and miR-H7* were up-regulated. Western blotting showed that SNS-032 strongly inhibited phosphorylation of STAT3 and protein expression of JAK2,C-MYC and MCL-1.</p><p><b>CONCLUSION</b>CDK inhibitor SNS-032 can induce apoptosis of AML HL-60 cells, which is associated with the inhibition of MCL-1,C-MYC and JAK2/STAT3, and down-regulation of miR-17-92 family.</p>


Subject(s)
Humans , Apoptosis , Cell Survival , Down-Regulation , Flow Cytometry , HL-60 Cells , Janus Kinase 2 , Metabolism , MicroRNAs , Metabolism , Oxazoles , Pharmacology , Phosphorylation , STAT3 Transcription Factor , Metabolism , Signal Transduction , Thiazoles , Pharmacology
2.
International Eye Science ; (12): 1822-1824, 2014.
Article in Chinese | WPRIM | ID: wpr-642058

ABSTRACT

AIM:To observe the clinical effect of femtosecond laser assisted penetrating keratoplasty. METHODS: Twenty-four cases ( 24 eyes ) with corneal lesions were performed with femtosecond laser assisted penetrating keratoplasty. Preoperative and postoperative endothelial cell density and visual quality were compared.RESULTS: One week after operation, corneal grafts were clear in 21 eyes (87. 5%), mild cloudy in 3 eyes (12.5%);visual acuity ≥0. 5 in 18 eyes (75. 0%), 0. 2 ~0.4 in 6 eyes ( 25. 0%). After 3mo the mean corneal astigmatism was 2. 16±0. 21D ( range 2. 25 ~ 3. 09D). Compared to conventional penetrating keratoplasty which mean corneal astigmatism was average 3. 67±0. 38D after operation, there was significant difference between two groups ( P CONCLUSION: Femtosecond laser assisted penetrating corneal transplantation operation can improve patient's visual quality. And compared to traditional penetrating keratoplasty astigmatism decreased significantly, incision can be made in individual shape more precisely and neatly.

3.
Chinese Journal of Hematology ; (12): 472-475, 2008.
Article in Chinese | WPRIM | ID: wpr-239993

ABSTRACT

<p><b>OBJECTIVE</b>To compare the differences in clinical therapeutic effect and safety between amphotericin B and its liposome form in treating invasive fungal infection (IFI) in hematological disorder with neutrocytopenia.</p><p><b>METHODS</b>Of 111 patients with IFI, 82 were treated with amphotericin B and 29 with amphotericin B liposome. The mean cumulative dose of amphotericin B was 617 (60-1895) mg and the mean course was 18 (7-60) d, and those for amphotericin B liposome was 925 (140-3420) mg and 13 (7-50) d, respectively.</p><p><b>RESULTS</b>The total effective rates of amphotericin B and its liposome groups were 69% and 58%, respectively (P>0.05). The adverse effect rates of chill and fever in amphotericin B and its liposome groups were 21% and 10% (P>0.05), hypopotassemia 34% and 14% (P=0.03), hepatic impairment 22% and 17% (P>0.05), and renal impairment 9% and 3%, respectively (P>0.05).</p><p><b>CONCLUSION</b>The therapeutic effect for IFI of amphotericin B and its liposome was similar. The severe adverse reaction of amphotericin B liposome was slightly lower than that of amphotericin B.</p>


Subject(s)
Humans , Agranulocytosis , Amphotericin B , Therapeutic Uses , Antifungal Agents , Therapeutic Uses , Hematologic Diseases , Liposomes , Therapeutic Uses , Mycoses , Drug Therapy , Retrospective Studies , Treatment Outcome
4.
Chinese Journal of Hematology ; (12): 9-12, 2008.
Article in Chinese | WPRIM | ID: wpr-262936

ABSTRACT

<p><b>OBJECTIVE</b>To analyse the outcome of newly diagnosed adult acute myeloid leukemia (AML) patients treated with HAA (homoharringtonine, cytarabine and aclarubicin) regimen and explore the efficacy and safety of this regimen.</p><p><b>METHODS</b>Eighty patients were treated with HAA regimen. The complete remission (CR) rate was observed. Kaplan-Meier method was used to estimate relapse free survival (RFS) rate and the differences were compared with 2-sided log-rank test.</p><p><b>RESULTS</b>Of the 80 patients, 65 (81%) attained CR and the CR rate after the first course of induction was 75%. For the CR patients, the median follow-up was 26 (2 -69) months, and the estimated 3-year overall survival (OS) rate was 51% and the estimated 3-year RFS was 53%. For the AML-M5 and AML-M /M2 patients the CR rate was 74% and 87% and 3 year RFS of CR patients was 75% and 37%, respectively. The CR rate of 100%, 83% and 20% was achieved in patients with favorable, intermediate and unfavorable cytogenetics, respectively. The 3 year OS for favorable and intermediate group was 76% and 50% respectively. The median survival time of unfavorable group was only 6 months.</p><p><b>CONCLUSION</b>HAA regimen is a safe, efficacious, and well-tolerable induction therapy for newly diagnosed AML.</p>


Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , Aclarubicin , Antineoplastic Combined Chemotherapy Protocols , Therapeutic Uses , Cytarabine , Harringtonines , Leukemia, Myeloid, Acute , Drug Therapy , Retrospective Studies , Treatment Outcome
5.
Journal of Applied Clinical Pediatrics ; (24)2006.
Article in Chinese | WPRIM | ID: wpr-640098

ABSTRACT

Objective To observe the effect of intravenous nutrition on blood serum triglyceride (TG),humoral immunity and cellular immunity function in premature infants.Methods Sixty premature infants were randomly divided into 3 groups:amino acid group (group A),amino acid plus medium-long chain fatty group (group B) and amino acid plus long chain fatty group (group C).Amino acid and the fatty were used on them from 24 hours after their birth,started from 1.0 g/(kg?d),increased progressively 0.5 g/(kg?d) until 3.0 g/(kg?d),totally 7 days.TG and immunoglobulin IgA,IgM,IgG,complement C3,C4 and T-lymphocyte subsets CD3,CD4,CD4/CD8 and NK cell were checked in the first day before treatment and the ninth day after treatment.Results Compared with before treatment,TG of 3 groups were elevated(Pa0.05).Compared with group A and B,NK cell in group C were decreased obviously(Pa

SELECTION OF CITATIONS
SEARCH DETAIL